Feature | April 15, 2011

Support Programs Aid Women With Heart Disease

WomenHeart is the only national organization dedicated to promoting women’s heart health through advocacy, education and patient support. As the leading voice for the 42 million American women living with or at risk of heart disease, WomenHeart advocates for equal access to quality care and provides information and resources to help women take charge of their heart health.

Lise Tate, CAE, CEO of WomenHeart, the National Coalition for Women With Heart Disease, said the nonprofit group helps set up hospital support groups to guide women through their treatment and recovery. Since its inception, WomenHeart – founded by three women heart attack survivors who transformed the isolation, confusion and ignorance about women’s heart disease into a rallying call to save women’s lives — has been at the forefront of providing support services to women with heart disease and educating policymakers, health professionals and the public about the urgent need to make women’s heart health a priority.

Founded in 1999, WomenHeart’s mission is to improve the health and quality of life of women living with or at risk of heart disease. Through our programs and services, WomenHeart raises awareness about the importance of prevention and early detection, accurate diagnosis and proper treatment of women’s heart disease.

WomenHeart is a coalition and a community of thousands of members nationwide, including women heart patients and their families, physicians, health advocates and consumers committed to helping women live longer, healthier lives. At the center of the organization are the more than 500 WomenHeart Champions, all heart disease survivors, who have graduated from WomenHeart’s Science and Leadership Symposium at the Mayo Clinic. These alumnae serve as WomenHeart local support group leaders, community educators, media spokeswomen, and general support volunteers.

Through leadership and advocacy training, information resources and an online community, WomenHeart empowers women living with heart disease to manage their own heart health and to help all women take charge of their heart health. For more information: www.womenheart.org

Related Content

NCDR, ACC, JACC, American College of Cardiology, national trends, heart disease treatments, trends in cardiovascular care
News | Cath Lab| January 23, 2017
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended thr
Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
News | Drug-Eluting Balloons| November 03, 2016
The Spectranetics Corp. announced that it has submitted to the U.S. Food & Drug Administration (FDA) its Pre-Market...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting| November 02, 2016
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
Medtronic, Harmony TPV, transcatheter pulmonary valve, clinical study results, TCT 2016
News | Heart Valve Technology| November 02, 2016
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
Overlay Init